Methylphenidate enhances extinction of contextual fear

Learning and Memory

Volumn 19, Issue 2, 2012, Pages 67-72

  Abraham, Antony D ^a   Cunningham, Christopher L ^a   Lattal, K Matthew ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR THERAPY; CONDITIONING; DOSE RESPONSE; DRUG EFFECT; FEAR; FOLLOW UP; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, CLASSICAL; EXTINCTION, PSYCHOLOGICAL; FEAR; MALE; METHYLPHENIDATE; MICE; MICE, INBRED C57BL;

EID: 84857230954     PISSN: 10720502     EISSN: 15495485     Source Type: Journal    
DOI: 10.1101/lm.024752.111     Document Type: Article

References (40)

1. Abel T, Lattal KM. 2001. Molecular mechanisms of memory acquisition, consolidation and retrieval. Curr Opin Neurobiol 11: 180-187. (Pubitemid 32289404)
2. Arnsten AFT, Dudley A. 2005. Methylphenidate improves prefrontal cortical cognitive function through α-2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder. Behav Brain Funct 1: 2-11.
3. Bernardi RE, Lattal KM. 2010. A role for a-adrenergic receptors in extinction of conditioned fear and cocaine conditioned place preference. Behav Neurosci 124: 204-210.
4. Bernardi RE, Ryabinin AE, Berger SP, Lattal KM. 2009. Post-retrieval disruption of a cocaine conditioned place preference by systemic and intrabasolateral amygdala β2- and α1-adrenergic antagonists. Learn Mem 16: 777-789.
5. Berridge CW, Devilbiss DM, Andrzejewski ME, Arnsten AFT, Kelley AE, Schmeichel B, Hamilton C, Spencer RC. 2006. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol Psychiatry 60: 1111-1120. (Pubitemid 44647216)
6. Borowski TB, Kokkinidis L. 1998. The effects of cocaine, amphetamine, and the dopamine D1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: Implications for psychomotor stimulant psychosis. Behav Neurosci 112: 952-965. (Pubitemid 28397378)
7. Bouton ME. 1993. Context, time and memory retrieval in the interference paradigms of Pavlovian learning. Psychol Bull 114: 80-99.
8. Bouton ME, Peck CA. 1992. Spontaneous recovery in cross-motivational transfer (counterconditioning). Anim Learn Behav 20: 313-321.
9. Burgos-Robles A, Vidal-Gonzalez I, Santini E, Quirk GJ. 2007. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron 53: 871-880. (Pubitemid 46367556)
10. Busti D, Geracitano R, Whittle N, Dalezios Y, Mańko M, Kaufmann W, Sätzler K, Singewald N, Capogna M, Ferraguti F. 2011. Different fear states engage distinct networks within the intercalated cell clusters of the amygdala. J Neurosci 31: 5131-5144.
11. Carmack SA, Wood SC, Anagnostaras SG. 2010. Amphetamine and extinction of cued fear. Neurosci Lett 468: 18-22.
12. 14C: Studies in man and animals. J Pharmacol Exp Ther 191: 535-547.
13. Gaytan O, al-RahimS, Swann A, Dafny N. 1997. Sensitization to locomotor effects of methylphenidate in the rat. Life Sci 61: 101-107.
14. Han DD, Gu HH. 2006. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6: 6. doi: 10.1186/1471-2210-6-6.
15. Hikind N, Maroun M. 2008. Microinfusion of the D1 receptor antagonist, SCH23390 into the IL but not the BLA impairs consolidation ofextinction of auditory fear conditioning. Neurobiol Learn Mem 90: 217-222.
16. Holtzmann-Assif O, Laurent V,Westbrook RF. 2010. Blockade of dopamine activity in the nucleus accumbens impairs learning extinction of conditioned fear. Learn Mem 17: 71-75.
17. Houlihan DJ. 2010. Psychostimulant treatment of combat-related posttraumatic stress disorder. J Psychopharmacol 25: 1568-1572.
18. Johansen EB, Aase H, Meyer A, Sagvolden T. 2002. Attention-deficit/ hyperactivity disorder behaviour explained by dysfunctioning reinforcement and extinction processes. Behav Brain Res 130: 37-45. (Pubitemid 34195319)
19. Maren S, Quirk GJ. 2004. Neuronal signaling of fear memory. Nat Rev Neurosci 5: 844-852.
20. Marsteller DA, Gerasimov MR, Schiffer WK, Geiger JM, Barnett CR, Schaich Borg J, Scott S, Ceccarelli J, Volkow ND, Molina PE, et al. 2002. Acute handling stress modulates methylphenidate-induced catecholamine overflow in the medial prefrontal cortex. Neuropsychopharmacology 27: 163-170. (Pubitemid 34686968)
21. Mazei MS, Pluto CP, Kirkbride B, Pehek EA. 2002. Effects of catecholamine uptake blockers in the caudate putamen and subregions of the medial prefrontal cortex of the rat. Brain Res 936: 58-67. (Pubitemid 34461933)
22. Miczek KA, Luttinger D. 1978. Differential attenuation of two kinds of conditioned suppression by d-amphetamine and pentobarbital. J Pharmacol Exp Ther 205: 282-290. (Pubitemid 8357774)
23. Mueller D, Olivera-Figueroa LA, Pine DS, Quirk GJ. 2009. The effects of yohimbine and amphetamine on fear expression and extinction in rats. Psychopharmacology 204: 599-606.
24. Myers KM, Davis M. 2007. Mechanisms of fear extinction. Mol Psychiatry 12: 120-150. (Pubitemid 46160979)
25. National Institutes of Health. 1985. NIH Publication 86-23 Revised. In Guide for the care and use of laboratory animals. Public Health Service, National Institutes of Health.
26. Nolley EP, Kelley BM. 2007. Adolescent reward system perseveration due to nicotine: Studies with methylphenidate. Neurotoxicol Teratol 29: 47-56. (Pubitemid 46205160)
27. Peters J, Kalivas PW, Quirk GJ. 2009. Extinction circuits for fear and addiction overlap in the prefrontal cortex. Learn Mem 16: 279-288.
28. Pezze MA, Feldon J. 2004. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 74: 301-320. (Pubitemid 39586721)
29. Pezze MA, Bast T, Feldon J. 2003. Significance of dopamine transmission in the rat medial prefrontal cortex for conditioned fear. Cereb Cortex 13: 371-380. (Pubitemid 36373683)
30. Quirk GJ, Mueller D. 2008. Neural mechanisms of extinction learning and retrieval. Neuropsychopharmacology 33: 56-72. (Pubitemid 350191313)
31. Quirk GJ, Garcia R, Gonzalez-Lima F. 2006. Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry 60: 337-343. (Pubitemid 44215848)
32. Shin LM, Rauch SL, Pitman RK. 2006. Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 1071: 67-79. (Pubitemid 44126721)
33. Skinner BF. 1948. Superstition in the pigeon. J Exp Psychol 38: 168-172.
34. Sorg BA, Kalivas PW. 1993. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience 53: 695-703. (Pubitemid 23114558)
35. Tye KM, Tye LD, Cone JJ, Hekkelman EF, Janak PH, Bonci A. 2010. Methylphenidate facilitates learning-induced amygdala plasticity. Nature 13: 475-481.
36. Vidal-Gonzalez I, Vidal-Gonzalez B, Rauch SL, Quirk GJ. 2006. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn Mem 13: 728-733. (Pubitemid 44871673)
37. Volkow ND, Ding YS, Fowler JS, Wang GJ, Logan J, Gatley JS, Dewey S, Ashby C, Liebermann J, Hitzemann R, et al. 1995. Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Arch Gen Psychiatry 52: 456-463.
38. Weber M, Hart J, Richardson R. 2007. Effects of D-cycloserine on extinction of learned fear to an olfactory cue. Neurobiol Learn Mem 87: 476-482. (Pubitemid 46483131)
39. Wu X, Gu H. 1999. Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233: 163-170. (Pubitemid 29353235)
40. Zheng XL, Liu F, Wu XW, Li BM. 2008. Infusion of methylphenidate into the basolateral nucleus of amygdala or anterior cingulate enhances fear memory consolidation in rats. Sci China C Life Sci 51: 808-813.